Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. (2022)
Attributed to:
Development of a serocorrelate of protection against invasive Group B Streptococcus disease (iGBS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2022.05.016
PubMed Identifier: 35779963
Publication URI: http://europepmc.org/abstract/MED/35779963
Type: Journal Article/Review
Volume: 40
Parent Publication: Vaccine
Issue: 32
ISSN: 0264-410X